Liminatus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIMN and other ETFs, options, and stocks.About LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
LIMN Key Statistics
Stock Snapshot
The current Liminatus Pharma(LIMN) stock price is $0.77, with a market capitalization of 20.95M. The stock trades at a price-to-earnings (P/E) ratio of -4.17.
On 2026-01-24, Liminatus Pharma(LIMN) stock moved within a range of $0.76 to $0.80. With shares now at $0.77, the stock is trading +1.1% above its intraday low and -4.1% below the session's peak.
Trading activity shows a volume of 30.63K, compared to an average daily volume of 101.45K.
Over the past 52 weeks, Liminatus Pharma(LIMN) stock has traded between a high of $33.66 and a low of $0.61.
Over the past 52 weeks, Liminatus Pharma(LIMN) stock has traded between a high of $33.66 and a low of $0.61.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.